MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
Leading Ventures
InflammaGen
Parents
*Architects: BioPharmaceuticals_Inflammation, Allergy & Autoimmune
*Industry: San Diego, California
Leading Ventures
Venture Capital: Angel, Seed & Incubator Series
Children
Geert Schmid-Schönbein, a professor of bioengineering at UC San Dieg
Hank Loy, a business development executive who now manages both InflammaGen and AnoZyme as the CEO of Leading Ventures’ portfolio companies.
San Diego, California
San Diego’s Leading Ventures Takes on Commercialization of Bioengineering Breakthroughs (2011)
Jumps
2022: UC San Diego receives $150 million pledge for stem cell research
Anozyme